GSWM
INSY

Golden State Wealth Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Golden State Wealth Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200
Closed -$1K – 1196
2019
Q1 		$1K Buy
+200
New +$947 ﹤0.01% 1102

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Golden State Wealth Management's INSY Position: Q2 2019 in Review

Golden State Wealth Management sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 200 shares — an estimated $1K sold.

Golden State Wealth Management first reported a position in INSY in Q1 2019 and held it in 1 quarter. The position peaked at $1K in Q1 2019. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Golden State Wealth Management reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Golden State Wealth Management sold 200 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $1K.
  • Golden State Wealth Management first reported a position in Insys Therapeutics, Inc. in Q1 2019 and held it in 1 quarter.
  • Golden State Wealth Management's Insys Therapeutics, Inc. position peaked at $1K in Q1 2019.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Golden State Wealth Management's 13F filing for Q2 2019, filed 9 Aug 2019.